Emmanuel spent much of his life battling the painful and life-limiting effects of sickle cell disease. Through a groundbreaking gene therapy clinical trial at Lurie Children’s, he is now living symptom-free—offering new hope for his future and for others facing this condition.
Featured in 2025 — check out his story below:
In March 2024, Mason became one of the first patients at Lurie Children’s to receive ELEVIDYS, a groundbreaking gene therapy for Duchenne muscular dystrophy—a rare genetic condition that causes progressive muscle weakness. With this innovative treatment, Mason’s family is filled with hope for his future and for his younger brother, Dawson, who may soon benefit as well.
Featured in 2024 — check out their video story below:
Ella was just 13 months old when she was diagnosed with a rare and aggressive form of leukemia. After intensive chemotherapy and a life-saving stem cell transplant at Lurie Children’s, she is now thriving in remission. Her journey is a powerful example of resilience, innovation, and the impact of personalized care.
Featured in 2023 — check out her story below: